z-logo
Premium
Successful treatment of facial vascular skin diseases with a 577‐nm pro‐yellow laser
Author(s) -
Mohamed EssamElden M.,
Mohamed Tawfik Khaled,
Hassan Ahmad Wafaa
Publication year - 2019
Publication title -
journal of cosmetic dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.626
H-Index - 44
eISSN - 1473-2165
pISSN - 1473-2130
DOI - 10.1111/jocd.12963
Subject(s) - medicine , dermatology , laser therapy , laser , optics , physics
Abstract Background Treatment of vascular skin diseases is one of the most important indications of the laser. Aims To evaluate the effectiveness of 577‐nm pro‐yellow laser in the treatment of some vascular skin diseases. Patients/methods Ninety‐five patients with vascular skin diseases were included in this prospective monocentric study. They were classified into: port‐wine stain birthmarks (n = 37), papulopustular rosacea (n = 20), facial telangiectasia (n = 16), and facial erythema (n = 22). All participants received a monthly session of 577‐nm pro‐yellow laser. Follow‐up was done by comparing the photographs before and at every follow‐up visit. Results At the final visit, there was a significant improvement (>50%) occurred in 24/37 (64.82%), 12/20 (60%), 10/16 (62.5%), and 19/22 (86.3%) cases and poor response occurred in 6/37 (16.2%), 2/20 (10%), 2/16 (12.5%), and 0/22 cases after a mean number of sessions 7.76 ± 2.28, 3.1 ± 1.8, 3.63 ± 1.12, and 1.8 ± 0.85 in port‐wine stain, rosacea‐, facial telangiectasia‐, and facial erythema‐treated groups, respectively. Transient irritation and erythema during the session were the only complications reported in the study. Conclusion Facial port‐wine stains, rosacea, telangiectasia, and erythema can be successfully treated with a single pass of 577‐nm pro‐yellow laser with a minimal side effect. Facial erythema showed the highest degree of success with the least number of sessions, while more sessions needed for the treatment of port‐wine stain.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here